After Zydus' Historic COVID-19 DNA Vaccine Approval, Inovio To Enter Phase III

Will Data Availability Hold Key To Acceptance?

Soon after Zydus Cadila won a historic accelerated approval in India for the world’s first plasmid DNA vaccine for human use, in this case against COVID-19, Inovio’s candidate is set to move to Phase III in Brazil. But will the new technology find wide acceptance?

DNA strand
Zydus Cadila Receives Approval For First Human Use Plasmid DNA Vaccine • Source: Alamy

An accelerated approval for Zydus Cadila’s COVID-19 vaccine from India's regulator has given the company global bragging rights to the first plasmid DNA vaccine for use in humans. Zy-CoV-D also becomes the first coronavirus vaccine to be given a nod for use in adolescents aged from 12 to 18 in India.

Surely that’s good press and something the Indian firm can rightfully list as a significant achievement, but Zydus Cadila will...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Approvals

More from Product Reviews

  • data

    New EU Filings

     
    • By 

    <p>Executive Summary</p> <p>Zanidatamab, Jazz and BeiGene’s investigational treatment for biliary tract cancer, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.</p>

  • data

    EU CHMP Opinions And MAA Updates

     
    • By 

    <p>Executive Summary</p> This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the EU, and updates on EU marketing authorization changes recommended by the CHMP.

  • EU Biosimilar Filings, Opinions And Approvals

     
    • By 

    <p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>